Caligan Partners LP
26 holdingsFiling period: 2026-06-30Current AUM: $2.03Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | LQDA | LIQUIDIA CORPORATION | 8.12M | $647.3M | $533.6M | 26.25% | -- | 2026-06-30 |
| 2 | RVMD | REVOLUTION MEDICINES INC | 2.21M | $414.6M | $453.5M | 22.31% | +331.9K | 2026-06-30 |
| 3 | ABVX | ABIVAX SA | 1.56M | $207.6M | $166.2M | 8.18% | +96.0K | 2026-06-30 |
| 4 | PCVX | VAXCYTE INC | 2.19M | $127.2M | $129.6M | 6.38% | +127.9K | 2026-06-30 |
| 5 | EXEL | EXELIXIS INC | 1.55M | $84.5M | $88.4M | 4.35% | -- | 2026-06-30 |
| 6 | TNGX | TANGO THERAPEUTICS INC | 2.50M | $78.2M | $59.7M | 2.94% | +91.3K | 2026-06-30 |
| 7 | AVTX | AVALO THERAPEUTICS INC | 3.16M | $58.5M | $50.8M | 2.50% | +1.53M | 2026-06-30 |
| 8 | XENE | XENON PHARMACEUTICALS INC | 889.9K | $53.7M | $50.1M | 2.46% | -503,083 | 2026-06-30 |
| 9 | ADMA | ADMA BIOLOGICS INC | 6.03M | $50.4M | $51.9M | 2.55% | +968.5K | 2026-06-30 |
| 10 | LBRX | LB PHARMACEUTICALS INC | 1.44M | $46.7M | $61.9M | 3.05% | -- | 2026-06-30 |
| 11 | IMCR | IMMUNOCORE HLDGS PLC | 1.38M | $43.9M | $43.9M | 2.16% | -- | 2026-06-30 |
| 12 | VRDN | VIRIDIAN THERAPEUTICS INC | 2.19M | $40.3M | $47.9M | 2.36% | -- | 2026-06-30 |
| 13 | VOR | VOR BIOPHARMA INC | 1.93M | $35.4M | $43.0M | 2.11% | -- | 2026-06-30 |
| 14 | SABS | SAB BIOTHERAPEUTICS INC | 7.97M | $31.1M | $27.2M | 1.34% | -- | 2026-06-30 |
| 15 | IVA | INVENTIVA SA | 8.16M | $30.9M | $31.5M | 1.55% | +3.19M | 2026-06-30 |
| 16 | AURA | AURA BIOSCIENCES INC | 4.30M | $30.5M | $29.7M | 1.46% | +4.07M | 2026-06-30 |
| 17 | TYRA | TYRA BIOSCIENCES INC | 807.0K | $25.8M | $20.5M | 1.01% | -469,982 | 2026-06-30 |
| 18 | IRD | OPUS GENETICS INC | 6.08M | $25.0M | $35.4M | 1.74% | +2.1K | 2026-06-30 |
| 19 | ANIK | ANIKA THERAPEUTICS INC | 1.44M | $21.0M | $30.0M | 1.48% | -- | 2026-06-30 |
| 20 | SGMT | SAGIMET BIOSCIENCES INC | 2.50M | $19.3M | $26.1M | 1.29% | -- | 2026-06-30 |
| 21 | ARTV | ARTIVA BIOTHERAPEUTICS INC | 1.74M | $16.8M | $15.5M | 0.76% | -- | 2026-06-30 |
| 22 | SNSE | FAETH THERAPEUTICS INC | 629.5K | $15.7M | $15.7M | 0.77% | +503.5K | 2026-06-30 |
| 23 | MBX | MBX BIOSCIENCES INC | 200.0K | $11.0M | $12.2M | 0.60% | -648,590 | 2026-06-30 |
| 24 | VRCA | VERRICA PHARMACEUTICALS INC | 923.9K | $5.7M | $4.2M | 0.21% | -- | 2026-06-30 |
| 25 | AGIO | AGIOS PHARMACEUTICALS INC | 90.0K | $3.3M | $3.0M | 0.15% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2